We based our rationale on the findings of Brugnara, Chambers, Malynn, Goldberg & Kruskall [41], who showed healthy subjects with serum ferritin levels <100 μg·L-1 developed a functional iron deficiency when undergoing synthetic EPO administration. Here, EPO is linked to Iron deficiency anemia.